RELATIONSHIP BETWEEN INVESTMENTS IN INTELLECTUAL CAPITAL AND TOTAL BOOK VALUE
Abstract
The research paper aims to empirically investigate the relationship between investments in intellectual capital and French pharmaceutical companies’ total book value. The multiple statistical regression analyses were done on 36 companies in the period from 2008 until 2016. The research models investigate the transformation process from expenses into concrete assets accepted and recognized by international accounting standards. The investments in structural capital component of intellectual capital influence negatively, with a coefficient of -0.00374. On the other side, investments in human capital and external capital compoments influence positively, with its coefficients 0.861388 and 0.077 respectively. The sample size, as well as the lack of available financial information related to the research and development (R&D) and marketing expenses disclosed in the company’s accounts, are two main limitations of the paper. These results prove that French pharmaceutical companies transform their long-term intellectual capital investments into asset value.
References
Arrighetti, A., Landini, F., & Lasagni, A. (2014). Intangible assets and firm heterogeneity: Evidence from Italy. Research Policy, 43(1), 202–213. https://doi.org/10.1016/j.respol.2013.07.015
Barnes, P., & McClure, A. (2009). Investments on intangible assets and Australia’s productivity growth. Productivity Comission.
Barney, J., Wright, M., & Ketchen, D. J. (2001). The resource-based view of the firm: Ten years after 1991. Journal of Management, 27(6), 625–641. https://doi.org/10.1177/014920630102700601
Battisti, G., Gallego, J., Rubalcaba, L., & Windrum, P. (2015). Open innovation in services: Knowledge sources, intellectual property rights and internationalization. Economics of Innovation and New Technology, 24(3), 223–247. https://doi.org/10.1080/10438599.2014.924745
Bhatti, S. H., Vorobyev, D., Zakariya, R., & Christofi, M. (2021). Social capital, knowledge sharing, work meaningfulness and creativity: Evidence from the Pakistani pharmaceutical industry. Journal of Intellectual Capital, 22(2), 243–259. https://doi.org/10.1108/JIC-02-2020-0065
Bontis, N., Janošević, S., & Dženopoljac, V. (2015). Intellectual capital in Serbia’s hotel industry. International Journal of Contemporary Hospitality Management, 27(6), 1365–1384. https://doi.org/10.1108/IJCHM-12-2013-0541
Carmeli, A., & Azeroual, B. (2009). How relational capital and knowledge combination capability enhance the performance of work units in a high technology industry: Relational Capital and Knowledge Combination Capability. Strategic Entrepreneurship Journal, 3(1), 85–103. https://doi.org/10.1002/sej.63
Chizari, M. hosein, Mehrjardi, R. Z., Sadrabadi, M. M., & Mehrjardi, F. K. (2016). The impact of Intellectual Capitals of Pharmaceutical Companies Listed in the Tehran Stock Exchange on their Market Performance. Procedia Economics and Finance, 36, 291–300. https://doi.org/10.1016/S2212-5671(16)30040-5
Daryaee, A., Pakdel, A., Easapour, K., & Khalaflu, M.M. (2011). Intellectual Capital, Corporate Value and Corporate Governance (Evidence from Tehran Stock Exchange (TSE). Australian Journal of Basic and Applied Sciences, 5, 821–826.
Department for Business Innovation & Skills. (2012). The Impact of Investment in Intangible Assets on Productivity Spillovers. Final Report for the Department for Business, Innovation and Skills Prepared by London Economics, 173.
Ding, Y., & Stolowy, H. (2007). R&D productivity: An exploratory international study. Review of Accounting and Finance, 6(1), 86–101. https://doi.org/10.1108/14757700710725476
Forecast: Industry revenue of “manufacture of basic pharmaceutical products“ in France 2012-2025. (n.d.). Statista. Retrieved August 27, 2022, from https://www.statista.com/forecasts/919050/manufacture-of-basic-pharmaceutical-products-revenue-in-france
Galbraith, J.K. (1969). The Consequences of Technology. Journal of Accountancy, 127, 44–56.
Ho, Y. K., Tjahjapranata, M., & Yap, C. M. (2006). Size, Leverage, Concentration, and R&D Investment in Generating Growth Opportunities*. The Journal of Business, 79(2), 851–876. https://doi.org/10.1086/499140
Hollanders, H., Es-Sadki, N., & Kanerva, M. M. (2016). European innovation scoreboard 2016. European Commission.
Triki-Damak, S., & Halioui, K. (2013). Accounting treatment of R&D expenditures and earnings management: An empirical study on French listed companies. Global Business and Economics Research Journal, 2(1), 50–71.
IFRS Foundation, (2010). International Accounting Standard 16, Property, Plant and Equipment, IFRS Publications, London.
IFRS Foundation, (2010). International Accounting Standard 38, Intangible Assets, IFRS Publications, London.
Kujansivu, P., & Lönnqvist, A. (2007). Investigating the value and efficiency of intellectual capital. Journal of Intellectual Capital, 8(2), 272–287. https://doi.org/10.1108/14691930710742844
Lentjushenkova, O., & Lapina, I. (2014). The Classification of the Intellectual Capital Investments of an Enterprise. Procedia - Social and Behavioral Sciences, 156, 53–57. https://doi.org/10.1016/j.sbspro.2014.11.118
Lev, B. (2001). Intangibles management, measurement and reporting. Brooking Institution Press, Washington D.C., 133.
Li, Y., Dai, J., & Cui, L. (2020). The impact of digital technologies on economic and environmental performance in the context of industry 4.0: A moderated mediation model. International Journal of Production Economics, 229, 107777. https://doi.org/10.1016/j.ijpe.2020.107777
Liu, C.-H., & Jiang, J.-F. (2020). Assessing the moderating roles of brand equity, intellectual capital and social capital in Chinese luxury hotels. Journal of Hospitality and Tourism Management, 43, 139–148. https://doi.org/10.1016/j.jhtm.2020.03.003
Mahmood, T., & Mubarik, M. S. (2020). Balancing innovation and exploitation in the fourth industrial revolution: Role of intellectual capital and technology absorptive capacity. Technological Forecasting and Social Change, 160, 120248. https://doi.org/10.1016/j.techfore.2020.120248
Mehralian, G., Rasekh, H. R., Akhavan, P., & Sadeh, M. R. (2012). The Impact of Intellectual Capital Efficiency on Market Value: An Empirical Study from Iranian Pharmaceutical Companies. 14.
Mignon, S., & Walliser, E. (2015). Éditorial. Connaissances, capital intellectuel et management de l’innovation. Innovations, 47(2), 5. https://doi.org/10.3917/inno.047.0005
Molodchik, M.A., Shakina, E.A., & Bykova, A.A. (2012). Intellectual Capital Transformation Evaluating Model. Journal of Intellectual Capital, 13(4), 444–461.
Mubarik, M. S., Chandran, V. G. R., & Devadason, E. S. (2018). Measuring Human Capital in Small and Medium Manufacturing Enterprises: What Matters? Social Indicators Research, 137(2), 605–623. https://doi.org/10.1007/s11205-017-1601-9
Nadeem, M., Zaman, R., Suleman, T., & Atawnah, N. (2021). CEO ability, career concerns, firms’ lifecycle and investments in intellectual capital. International Review of Economics & Finance, 75, 237–251. https://doi.org/10.1016/j.iref.2021.04.023
Noordin, M. A., & Mohtar, S. (2013). An exploratory of the intangible assets: Methods of measuring intellectual capital. International Journal of Humanities and Applied Sciences, 2(2), 36-40.
OECD (2013). Supporting investment in knowledge capital, growth and innovation. OECD.
Pal, K., & Soriya, S. (2012). IC performance of Indian pharmaceutical and textile industry. Journal of Intellectual Capital, 13(1), 120–137. https://doi.org/10.1108/14691931211196240
Pap, E., Petković, M., & Simićević, A. (2021). Measuring distribution of intellectual capital components contribution: French context. The European Journal of Applied Economics, 18(1), 1–14. https://doi.org/10/gncdn3
Petković, M., & Đorđević, M. (2021). Intellectual Capital Investments and Company’s Profitability: French Context. Economic Analysis, 54(1), 14. https://doi.org/10.28934/ea.21.54.1.pp104-117
Petkovic, M., Krstic, B., & Randjelovic, T. (2021). Intellectual capital investments as the driver of future company performance. 67(april-june 2021), 1–11.
Pharma industry employees in Europe by country 2020. (n.d.). Statista. Retrieved August 27, 2022, from https://www.statista.com/statistics/315970/european-pharmaceutical-industry-employees-by-country/
Rezaei, M., Jafari-Sadeghi, V., & Bresciani, S. (2020). What drives the process of knowledge management in a cross-cultural setting: The impact of social capital. European Business Review, 32(3), 485–511. https://doi.org/10.1108/EBR-06-2019-0127
Sakas, D., Vlachos, D., & Nasiopoulos, D. (2014). Modelling strategic management for the development of competitive advantage, based on technology. Journal of Systems and Information Technology, 16(3), 187–209. https://doi.org/10.1108/JSIT-01-2014-0005
Saxena, G. (2015). Imagined relational capital: An analytical tool in considering small tourism firms’ sociality. Tourism Management, 49, 109–118. https://doi.org/10.1016/j.tourman.2015.03.002
Sharabati, A. A., Naji Jawad, S., & Bontis, N. (2010). Intellectual capital and business performance in the pharmaceutical sector of Jordan. Management Decision, 48(1), 105–131. https://doi.org/10.1108/00251741011014481
Tanideh, S. (2013). Relationship between innovation capital and intellectual capital with value and financial performance. Life Science Journal, 10, 251–254.
Thakur–Wernz, P., & Wernz, C. (2022). Impact of stronger intellectual property rights regime on innovation: Evidence from de alio versus de novo Indian bio-pharmaceutical firms. Journal of Business Research, 138, 457–473. https://doi.org/10.1016/j.jbusres.2021.08.074
Guidara, R., & Boujelbene, Y. (2015). R&D expenditures and earnings targets: Evidence from France. Journal of Economics, Finance and Accounting, 2(2), 164-180.
Zlatković, M. (2018). Intellectual capital and organizational effectiveness: PLS-SEM approach. Industrija, 46(4), 145–169. https://doi.org/10.5937/industrija46-19478
